English

ASSEMBLY BIOSCIENCES, INC.

EDGAR

ASMB Quarterly report (10-Q) · filed 2026-08-13

Annual consolidated revenue for 2025: about USD 72.3M, using the latest reported figures. The previous period, 2024, was about USD 28.52M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.89 million USD

2019 Q1 · USD

Exact inputs and evidence

Revenue: 3885000 USD Source

Operating margin

-729.37%

2019 Q1 · %

Exact inputs and evidence

Operating Income: -28336000 USD Source
Revenue: 3885000 USD Source

Operating cash flow

-23.9 million USD

2019 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -23939000 USD Source

Free cash flow

-25.4 million USD

2019 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -23939000 USD Source
Capital Expenditure: 1488000 USD Source

Cash and cash equivalents: 32.3 million USD 2026-06-30 Source
Exact value

32286000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 19.9 million shares 2026-06-30 Source
Exact value

19850342 shares

Reported share-count change

158.73% · 12.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

7672249 shares · 2025-06-30· Source
19850342 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-42 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -9196000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -6122000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -28212000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -9079000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -3857000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-38.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -55330000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -40197000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -41093000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -55330000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -22097000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -37585000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -22097000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

85 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 42000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 66000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 42000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-38.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -55330000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -40197000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -41093000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -55330000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -22097000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -37585000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -22097000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 42000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 66000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 42000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 19000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 2 of 11 periods available· newest 2025-12-31
Total liabilities: 2 of 11 periods available· newest 2025-12-31
Current assets: 2 of 11 periods available· newest 2025-12-31
Current liabilities: 2 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+153.5%

Prior period

USD 28.52 million

2024-01-01 – 2024-12-31
Current period

USD 72.3 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

72303000 − 28520000 = 43783000 USD

28520000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
72303000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Year-over-year change in Revenue: 43783000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 72303000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#3217551 Filing: 000119312526115992 Input fundies:Revenue: 28520000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#3219320 Filing: 000119312526115992
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 34.06 million

Prior period

−USD 40.18 million

2024-01-01 – 2024-12-31
Current period

−USD 6.12 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-6122000 − -40177000 = 34055000 USD

-40177000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-6122000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Year-over-year change in Net income: 34055000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6122000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#3282961 Filing: 000119312526115992 Input fundies:NetIncome: -40177000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#3284921 Filing: 000119312526115992
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 10.02 million

Prior period

−USD 51.12 million

2024-01-01 – 2024-12-31
Current period

−USD 41.09 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-41093000 − -51117000 = 10024000 USD

-51117000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-41093000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Year-over-year change in Operating cash flow: 10024000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -41093000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1908225 Filing: 000119312526115992 Input fundies:OperatingCashFlow: -51117000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1909976 Filing: 000119312526115992
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+135.7%

Prior period

USD 28,000

2024-01-01 – 2024-12-31
Current period

USD 66,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

66000 − 28000 = 38000 USD

28000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
66000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Year-over-year change in Capital expenditure: 38000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 66000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1925278 Filing: 000119312526115992 Input fundies:CapitalExpenditure: 28000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1927016 Filing: 000119312526115992
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 72.3 million 100% of revenue
Operating costs Derived USD 84.42 million 117% of revenue
Operating income −USD 12.12 million −17% of revenue
Tax, interest and other Derived −USD 6 million −8.3% of revenue
Net income −USD 6.12 million −8.5% of revenue

Cash

Operating cash flow −USD 41.09 million −57% of revenue
Capital expenditure USD 66,000 0.1% of revenue
Free cash flow Derived −USD 41.16 million −57% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2024 Operating loss: operating costs were 259% of revenue.
2025 Operating loss: operating costs were 117% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2024 2024-01-01 – 2024-12-31	28520000	73940000 Derived	-45420000	-5243000 Derived	-40177000	-51145000 Derived	Source 2024-01-01 – 2024-12-31: 28520000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -45420000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -40177000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -51117000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 28000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	72303000	84421000 Derived	-12118000	-5996000 Derived	-6122000	-41159000 Derived	Source 2025-01-01 – 2025-12-31: 72303000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -12118000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -6122000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -41093000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 66000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 72.3M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20242024-12-31	Revenue	28520000	Revenue: 28520000 Open source
20252025-12-31	Revenue	72303000	Revenue: 72303000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

153.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20242024-12-31	Year over year	No prior comparable period	Revenue: 28520000 Open source
20252025-12-31	Year over year	153.5%	Revenue: 72303000 Open source Revenue: 28520000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -16.8% 2025

Net margin -8.5% 2025

Free cash flow margin -56.9% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20242024-12-31	Operating margin	-159.3%	Operating Income: -45420000 Open source Revenue: 28520000 Open source
20252025-12-31	Operating margin	-16.8%	Operating Income: -12118000 Open source Revenue: 72303000 Open source
20242024-12-31	Net margin	-140.9%	Net Income: -40177000 Open source Revenue: 28520000 Open source
20252025-12-31	Net margin	-8.5%	Net Income: -6122000 Open source Revenue: 72303000 Open source
20242024-12-31	Free cash flow margin	-179.3%	Revenue: 28520000 Open source Operating Cash Flow: -51117000 Open source Capital Expenditure: 28000 Open source
20252025-12-31	Free cash flow margin	-56.9%	Revenue: 72303000 Open source Operating Cash Flow: -41093000 Open source Capital Expenditure: 66000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -41.1M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20242024-12-31	Operating cash flow	-51117000	Operating Cash Flow: -51117000 Open source
20252025-12-31	Operating cash flow	-41093000	Operating Cash Flow: -41093000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -41.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20242024-12-31	Free cash flow	-51145000	Operating Cash Flow: -51117000 Open source Capital Expenditure: 28000 Open source
20252025-12-31	Free cash flow	-41159000	Operating Cash Flow: -41093000 Open source Capital Expenditure: 66000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

19.7% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20242024-12-31	Liabilities / assets	72%	Total Liabilities: 85809000 Open source Total Assets: 119168000 Open source
20252025-12-31	Liabilities / assets	19.7%	Total Liabilities: 50839000 Open source Total Assets: 257590000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.22× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20242024-12-31	Current assets / current liabilities	2.42×	Current Assets: 115503000 Open source Current Liabilities: 47803000 Open source
20252025-12-31	Current assets / current liabilities	5.22×	Current Assets: 254549000 Open source Current Liabilities: 48780000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 44.26 million Exact value Exact value: -44261000 USD 2016-01-01 – 2016-12-31: -44261000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2016-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -44261000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44261000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/asmb-20181231.xml#748491 Filing: 000114420419011361 The citation records this snapshot. The page link may show a newer release later.	−USD 34.88 million Exact value Exact value: -34882000 USD 2016-01-01 – 2016-12-31: -34882000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2016-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -34882000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34882000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/asmb-20181231.xml#755800 Filing: 000114420419011361 The citation records this snapshot. The page link may show a newer release later.	USD 147,000 Exact value Exact value: 147000 USD 2016-01-01 – 2016-12-31: 147000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2016-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 147000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 147000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/asmb-20181231.xml#756409 Filing: 000114420419011361 The citation records this snapshot. The page link may show a newer release later.	−USD 35.03 million Calculation and evidence -34882000 − 147000 USD Exact free cash flow: -35029000 USD 2016-01-01 – 2016-12-31: -34882000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 147000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2016-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -35029000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34882000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/asmb-20181231.xml#755800 Filing: 000114420419011361 Input fundies:CapitalExpenditure: 147000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/asmb-20181231.xml#756409 Filing: 000114420419011361 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 42.81 million Exact value Exact value: -42809000 USD 2017-01-01 – 2017-12-31: -42809000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2017-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -42809000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42809000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/asmb-10k_20191231.htm#1959058 Filing: 000156459020008696 The citation records this snapshot. The page link may show a newer release later.	USD 1.86 million Exact value Exact value: 1860000 USD 2017-01-01 – 2017-12-31: 1860000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2017-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: 1860000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1860000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/asmb-10k_20191231.htm#2278869 Filing: 000156459020008696 The citation records this snapshot. The page link may show a newer release later.	USD 865,000 Exact value Exact value: 865000 USD 2017-01-01 – 2017-12-31: 865000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2017-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 865000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 865000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/asmb-10k_20191231.htm#2294756 Filing: 000156459020008696 The citation records this snapshot. The page link may show a newer release later.	USD 995,000 Calculation and evidence 1860000 − 865000 USD Exact free cash flow: 995000 USD 2017-01-01 – 2017-12-31: 1860000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 865000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2017-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: 995000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1860000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/asmb-10k_20191231.htm#2278869 Filing: 000156459020008696 Input fundies:CapitalExpenditure: 865000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/asmb-10k_20191231.htm#2294756 Filing: 000156459020008696 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 90.75 million Exact value Exact value: -90751000 USD 2018-01-01 – 2018-12-31: -90751000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2018-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -90751000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -90751000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#1879666 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.	−USD 64.96 million Exact value Exact value: -64958000 USD 2018-01-01 – 2018-12-31: -64958000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2018-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -64958000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64958000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2205383 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.	USD 340,000 Exact value Exact value: 340000 USD 2018-01-01 – 2018-12-31: 340000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2018-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 340000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 340000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2221314 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.	−USD 65.3 million Calculation and evidence -64958000 − 340000 USD Exact free cash flow: -65298000 USD 2018-01-01 – 2018-12-31: -64958000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 340000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2018-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -65298000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64958000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2205383 Filing: 000156459021008878 Input fundies:CapitalExpenditure: 340000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2221314 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 97.63 million Exact value Exact value: -97634000 USD 2019-01-01 – 2019-12-31: -97634000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2019-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -97634000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97634000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#1975478 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.	−USD 84.07 million Exact value Exact value: -84067000 USD 2019-01-01 – 2019-12-31: -84067000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2019-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -84067000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -84067000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2203524 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.	USD 1.55 million Exact value Exact value: 1554000 USD 2019-01-01 – 2019-12-31: 1554000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2019-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 1554000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1554000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2219531 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.	−USD 85.62 million Calculation and evidence -84067000 − 1554000 USD Exact free cash flow: -85621000 USD 2019-01-01 – 2019-12-31: -84067000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1554000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2019-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -85621000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -84067000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2203524 Filing: 000156459021008878 Input fundies:CapitalExpenditure: 1554000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459021008878/asmb-10k_20201231.htm#2219531 Filing: 000156459021008878 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 62.15 million Exact value Exact value: -62152000 USD 2020-01-01 – 2020-12-31: -62152000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2020-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -62152000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62152000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459022009855/asmb-10k_20211231.htm#2208328 Filing: 000156459022009855 The citation records this snapshot. The page link may show a newer release later.	−USD 62.96 million Exact value Exact value: -62957000 USD 2020-01-01 – 2020-12-31: -62957000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2020-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -62957000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62957000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459022009855/asmb-10k_20211231.htm#1721788 Filing: 000156459022009855 The citation records this snapshot. The page link may show a newer release later.	USD 470,000 Exact value Exact value: 470000 USD 2020-01-01 – 2020-12-31: 470000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2020-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 470000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 470000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459022009855/asmb-10k_20211231.htm#1732769 Filing: 000156459022009855 The citation records this snapshot. The page link may show a newer release later.	−USD 63.43 million Calculation and evidence -62957000 − 470000 USD Exact free cash flow: -63427000 USD 2020-01-01 – 2020-12-31: -62957000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 470000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2020-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -63427000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -62957000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459022009855/asmb-10k_20211231.htm#1721788 Filing: 000156459022009855 Input fundies:CapitalExpenditure: 470000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000156459022009855/asmb-10k_20211231.htm#1732769 Filing: 000156459022009855 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 129.86 million Exact value Exact value: -129855000 USD 2021-01-01 – 2021-12-31: -129855000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2021-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -129855000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -129855000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017023009184/asmb-20221231.htm#2337970 Filing: 000095017023009184 The citation records this snapshot. The page link may show a newer release later.	−USD 93.4 million Exact value Exact value: -93396000 USD 2021-01-01 – 2021-12-31: -93396000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2021-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -93396000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -93396000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017023009184/asmb-20221231.htm#1850801 Filing: 000095017023009184 The citation records this snapshot. The page link may show a newer release later.	USD 3.1 million Exact value Exact value: 3096000 USD 2021-01-01 – 2021-12-31: 3096000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2021-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 3096000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3096000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017023009184/asmb-20221231.htm#1875158 Filing: 000095017023009184 The citation records this snapshot. The page link may show a newer release later.	−USD 96.49 million Calculation and evidence -93396000 − 3096000 USD Exact free cash flow: -96492000 USD 2021-01-01 – 2021-12-31: -93396000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3096000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2021-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -96492000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -93396000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017023009184/asmb-20221231.htm#1850801 Filing: 000095017023009184 Input fundies:CapitalExpenditure: 3096000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017023009184/asmb-20221231.htm#1875158 Filing: 000095017023009184 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 93.09 million Exact value Exact value: -93092000 USD 2022-01-01 – 2022-12-31: -93092000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2022-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -93092000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -93092000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017024038057/asmb-20231231.htm#1672625 Filing: 000095017024038057 The citation records this snapshot. The page link may show a newer release later.	−USD 84.46 million Exact value Exact value: -84463000 USD 2022-01-01 – 2022-12-31: -84463000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2022-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -84463000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -84463000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017024038057/asmb-20231231.htm#1370125 Filing: 000095017024038057 The citation records this snapshot. The page link may show a newer release later.	USD 102,000 Exact value Exact value: 102000 USD 2022-01-01 – 2022-12-31: 102000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2022-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 102000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 102000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017024038057/asmb-20231231.htm#1382558 Filing: 000095017024038057 The citation records this snapshot. The page link may show a newer release later.	−USD 84.57 million Calculation and evidence -84463000 − 102000 USD Exact free cash flow: -84565000 USD 2022-01-01 – 2022-12-31: -84463000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 102000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2022-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -84565000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -84463000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017024038057/asmb-20231231.htm#1370125 Filing: 000095017024038057 Input fundies:CapitalExpenditure: 102000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017024038057/asmb-20231231.htm#1382558 Filing: 000095017024038057 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 61.23 million Exact value Exact value: -61228000 USD 2023-01-01 – 2023-12-31: -61228000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2023-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -61228000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61228000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017025042673/asmb-20241231.htm#2839329 Filing: 000095017025042673 The citation records this snapshot. The page link may show a newer release later.	USD 22.74 million Exact value Exact value: 22743000 USD 2023-01-01 – 2023-12-31: 22743000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2023-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: 22743000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 22743000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017025042673/asmb-20241231.htm#1652945 Filing: 000095017025042673 The citation records this snapshot. The page link may show a newer release later.	USD 255,000 Exact value Exact value: 255000 USD 2023-01-01 – 2023-12-31: 255000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2023-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 255000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 255000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017025042673/asmb-20241231.htm#1672344 Filing: 000095017025042673 The citation records this snapshot. The page link may show a newer release later.	USD 22.49 million Calculation and evidence 22743000 − 255000 USD Exact free cash flow: 22488000 USD 2023-01-01 – 2023-12-31: 22743000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 255000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2023-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: 22488000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 22743000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017025042673/asmb-20241231.htm#1652945 Filing: 000095017025042673 Input fundies:CapitalExpenditure: 255000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000095017025042673/asmb-20241231.htm#1672344 Filing: 000095017025042673 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 40.18 million Exact value Exact value: -40177000 USD 2024-01-01 – 2024-12-31: -40177000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2024-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -40177000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40177000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#3284921 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.	−USD 51.12 million Exact value Exact value: -51117000 USD 2024-01-01 – 2024-12-31: -51117000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2024-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -51117000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51117000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1909976 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.	USD 28,000 Exact value Exact value: 28000 USD 2024-01-01 – 2024-12-31: 28000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2024-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 28000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1927016 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.	−USD 51.15 million Calculation and evidence -51117000 − 28000 USD Exact free cash flow: -51145000 USD 2024-01-01 – 2024-12-31: -51117000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 28000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2024-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -51145000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51117000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1909976 Filing: 000119312526115992 Input fundies:CapitalExpenditure: 28000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1927016 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 6.12 million Exact value Exact value: -6122000 USD 2025-01-01 – 2025-12-31: -6122000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Net Income: -6122000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6122000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#3282961 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.	−USD 41.09 million Exact value Exact value: -41093000 USD 2025-01-01 – 2025-12-31: -41093000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Operating Cash Flow: -41093000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41093000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1908225 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.	USD 66,000 Exact value Exact value: 66000 USD 2025-01-01 – 2025-12-31: 66000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Capital Expenditure: 66000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 66000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1925278 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.	−USD 41.16 million Calculation and evidence -41093000 − 66000 USD Exact free cash flow: -41159000 USD 2025-01-01 – 2025-12-31: -41093000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 66000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASSEMBLY BIOSCIENCES, INC. · 2025-12-31 ASSEMBLY BIOSCIENCES, INC. (edgar:1426800) Free cash flow: -41159000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-04T13:56:18Z Snapshot: e5553e5f09f6c183dba851526d09eb62cbf7e7533c26780b6118d3c864d52c7f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1426800?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41093000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1908225 Filing: 000119312526115992 Input fundies:CapitalExpenditure: 66000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1426800/000119312526115992/asmb-20251231.htm#1925278 Filing: 000119312526115992 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

142 filings · 3,652 latest values · 3,652 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001426800, 1426800, ASMB, VTUS, edgar:1426800

Also known as ASSEMBLY BIOSCIENCES, INC., ASSEMBLY BIOSCIENCES, INC. , ASSEMBLY BIOSCIENCES, INC., Assembly Biosciences, Inc., VENTRUS BIOSCIENCES INC

ASSEMBLY BIOSCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation